HSP90B1 and neoplasm: In addition to the prevaccination expression levels of ALC, PBMCs, and PD-L1 being predictive markers of the gp96 tumor vaccine, we also found that the T cell receptor repertoire was a prognostic marker for the gp96 vaccine [29].